AU5416898A - Cisplatinum comprising pharmaceutical - Google Patents

Cisplatinum comprising pharmaceutical

Info

Publication number
AU5416898A
AU5416898A AU54168/98A AU5416898A AU5416898A AU 5416898 A AU5416898 A AU 5416898A AU 54168/98 A AU54168/98 A AU 54168/98A AU 5416898 A AU5416898 A AU 5416898A AU 5416898 A AU5416898 A AU 5416898A
Authority
AU
Australia
Prior art keywords
cisplatinum
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54168/98A
Inventor
Ben De Kruijff
Jan Reedijk
Gelske Speelmans
Rutger Willibrordus Hendricus Maria Staffhorst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rijksuniversiteit Utrecht
Original Assignee
Rijksuniversiteit Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rijksuniversiteit Utrecht filed Critical Rijksuniversiteit Utrecht
Publication of AU5416898A publication Critical patent/AU5416898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU54168/98A 1996-12-03 1997-12-03 Cisplatinum comprising pharmaceutical Abandoned AU5416898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WONL9600474 1996-12-03
PCT/NL1996/000474 WO1998024424A1 (en) 1996-12-03 1996-12-03 Cisplatinum comprising pharmaceutical
PCT/NL1997/000661 WO1998024425A1 (en) 1996-12-03 1997-12-03 Cisplatinum comprising pharmaceutical

Publications (1)

Publication Number Publication Date
AU5416898A true AU5416898A (en) 1998-06-29

Family

ID=19866012

Family Applications (2)

Application Number Title Priority Date Filing Date
AU77110/96A Abandoned AU7711096A (en) 1996-12-03 1996-12-03 Cisplatinum comprising pharmaceutical
AU54168/98A Abandoned AU5416898A (en) 1996-12-03 1997-12-03 Cisplatinum comprising pharmaceutical

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU77110/96A Abandoned AU7711096A (en) 1996-12-03 1996-12-03 Cisplatinum comprising pharmaceutical

Country Status (2)

Country Link
AU (2) AU7711096A (en)
WO (2) WO1998024424A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9186322B2 (en) 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
KR20050038011A (en) * 2002-08-02 2005-04-25 트랜세이브, 인코포레이티드 Platinum aggregates and process for producing the same
WO2004098524A2 (en) * 2003-05-02 2004-11-18 Aronex Pharmaceuticals, Inc. Lipid platinum complexes and methods of use thereof
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
CN115414384A (en) 2012-09-04 2022-12-02 埃莱森制药有限责任公司 Prevention of pulmonary recurrence of cancer with cisplatin lipid complexes
MX370673B (en) 2014-06-11 2019-12-19 Univ Texas Texaphyrin-pt(iv) conjugates and compositions for use in overcoming platinum resistance.
CN109745338B (en) * 2019-01-17 2021-03-30 南开大学 Preparation method and application of Pt (IV) polymer prodrug micelle encapsulating vorinostat and having reduction response

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
EP0792143B1 (en) * 1994-11-18 2002-09-04 Aphios Corporation Methods for making liposomes containing hydrophobic drugs

Also Published As

Publication number Publication date
AU7711096A (en) 1998-06-29
WO1998024425A1 (en) 1998-06-11
WO1998024424A1 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU6740298A (en) Pharmaceutical composition
AU5387898A (en) Pharmaceutical agents
AU8495998A (en) Improved dosage units
AU1409100A (en) Drugs
GB9715490D0 (en) Pharmaceutical preparation
AU8591898A (en) Pharmaceutical compounds
EP0907644A4 (en) Pharmaceutical preparation
AU4330097A (en) Pharmaceutical compounds
AU2531295A (en) Pharmaceutical composition
ZA982073B (en) Pharmaceutical preparation
AU9343098A (en) Pharmaceutical composition
GB9408053D0 (en) Pharmaceutical preparation
AU7711096A (en) Cisplatinum comprising pharmaceutical
AU4169897A (en) Pharmaceutical compounds
AU1475595A (en) Pharmaceutical preparation
AU1688099A (en) Pharmaceutical preparation
AP9801196A0 (en) Pharmaceutical preparation
AU2043295A (en) Antiulcer drug
AU5182099A (en) Pharmaceutical formulation
AU2279800A (en) Pharmaceutical preparation
AU5049098A (en) Pharmaceutical formulation
AUPP574298A0 (en) Pharmaceutical preparation
AU4948297A (en) Pharmaceutical preparation